General Information of the Compound
| Compound ID |
CP0418933
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]oxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H32O10
|
||||||||||||||||||
| Molecular Weight |
564.587
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)[C@@H]1C[C@H](OC(=O)\C=C\c2ccc3OCOc3c2)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@@H](C[C@]21C)c1ccoc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H32O10/c1-30-10-8-19-29(35)41-24(18-9-11-37-15-18)14-31(19,2)27(30)26(33)23(13-20(30)28(34)36-3)40-25(32)7-5-17-4-6-21-22(12-17)39-16-38-21/h4-7,9,11-12,15,19-20,23-24,27H,8,10,13-14,16H2,1-3H3/b7-5+/t19-,20-,23-,24-,27-,30-,31-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WYYKJTQJARVRLI-PRSJBHDFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor